Rituximab for systemic sclerosis: arrest of pulmonary disease progression in five cases Results of a lower dosage and shorter interval regimen. (May 2014) - Moazedi-Fuerst, FC; Kielhauser, SM; Brickmann, K; Hermann, J; Lutfi, A; Meilinger, M; Brezinschek, HP; Graninger, WB